Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 12.65

(-1.94%)

Operating Expenses Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual operating expenses in 2023 was 592 Thousand TWD , up 44.32% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly operating expenses in 2024 Q2 was 12.18 Million TWD , up 0.76% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a annual operating expenses of 32.07 Million TWD in annual operating expenses 2022, up 505.21% from previous year.
  • Mercury Biopharmaceutical Corporation reported a annual operating expenses of 5.29 Million TWD in annual operating expenses 2021, up 2423.33% from previous year.
  • Mercury Biopharmaceutical Corporation reported a quarterly operating expenses of 12.09 Million TWD for 2024 Q1, down -12.11% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a quarterly operating expenses of 9.62 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Expenses20192019.520202020.520212021.520222022.520230 TWD10000000 TWD20000000 TWD30000000 TWD40000000 TWD

Historical Annual Operating Expenses of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 592 Thousand TWD 44.32%
2022 32.07 Million TWD 505.21%
2021 5.29 Million TWD 2423.33%
2020 210 Thousand TWD 0.0%
2019 - TWD 0.0%

Peer Operating Expenses Comparison of Mercury Biopharmaceutical Corporation

Name Operating Expenses Operating Expenses Difference
Allied Biotech Corporation 157.72 Million TWD 99.625%
GeneFerm Biotechnology Co., Ltd. 132.78 Million TWD 99.554%
Easywell Biomedicals, Inc. 333.45 Million TWD 99.822%
TTY Biopharm Company Limited 1.91 Billion TWD 99.969%
Synmosa Biopharma Corporation 1.49 Billion TWD 99.961%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 99.972%
Center Laboratories, Inc. 697.35 Million TWD 99.915%
Tien Liang BioTech Co., Ltd. 267.27 Million TWD 99.779%
Orient Pharma Co., Ltd. 468.66 Million TWD 99.874%
InnoPharmax Inc. 82.29 Million TWD 99.281%
Johnson Chemical Pharmaceutical Works Co., Ltd. 244.63 Million TWD 99.758%
Excelsior Biopharma Inc. 388.05 Million TWD 99.847%
DV Biomed Co., Ltd. 575.24 Million TWD 99.897%
Foresee Pharmaceuticals Co., Ltd. 1.12 Billion TWD 99.947%
Handa Pharmaceuticals, Inc. 399.14 Million TWD 99.852%
UniPharma Co., Ltd. 78.32 Million TWD 99.244%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 99.851%
Alar Pharmaceuticals Inc. 83.74 Million TWD 99.293%
Winston Medical Supply Co., Ltd. 151.49 Million TWD 99.609%
Bioray Biotech Co., Ltd 96.98 Million TWD 99.39%
TSH Biopharm Corporation Limited 336.26 Million TWD 99.824%